OR03-5 A phase 2, multicenter, multiple-dose, open-label, parallel-group, active controlled, safety, tolerability, pharmacokinetic and pharmacodynamic study of ACP-001 in adult patients with Growth Hormone Deficiency (AGHD)

✍ Scribed by Höybye, C.; Pfeiffer, A.F.H.; Ferone, D.; Gilfoyle, D.; Beckert, M.; Christiansen, J.S.

• Book ID: 122102086
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 172 KB
• Volume: 22
• Category: Article
• ISSN: 1096-6374
• DOI: 10.1016/S1096-6374(12)60024-0